Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer's Disease and Neurogenesis.

Aging cell·2026
Same author

Cambridge Neuropsychological Test Automated Battery (CANTAB) and Cogstate Normative Data of Australian 12- and 13-Year-Olds.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same author

Neuropsychological subtypes of incident mild cognitive impairment and mild neurocognitive disorder in a population-based cohort of older adults.

Journal of Alzheimer's disease : JAD·2026
Same author

Age-related inhibitory decline: Examining inhibition subcomponents and their impact on sustained attention in healthy aging.

Neuropsychology·2025
Same author

Relationships between GABA + and Glx concentrations with age and inhibition in healthy older adults.

Brain structure & function·2025
Same author

Using cluster analysis to identify the health literacy strengths and challenges of people living with motor neurone disease in Australia.

BMC health services research·2025

Related Experiment Video

Updated: Mar 9, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

Multimodal emotion processing deficits are present in amyotrophic lateral sclerosis.

Sophie C Andrews1, Mathew Staios2, Jim Howe1

  • 1Neuropsychology Department, Calvary Health Care Bethlehem.

Neuropsychology
|January 6, 2017
PubMed
Summary

Individuals with amyotrophic lateral sclerosis (ALS) without dementia often experience subtle deficits in recognizing emotions in faces and voices, impacting social interactions and quality of life.

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.4K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

36.1K

Related Experiment Videos

Last Updated: Mar 9, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.4K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

36.1K

Area of Science:

  • Neuroscience
  • Psychology
  • Neurology

Background:

  • Emotion processing deficits may occur in amyotrophic lateral sclerosis (ALS).
  • Previous research on emotion processing in ALS yields inconsistent results due to methodological variations.
  • Assessing emotion processing in nondemented ALS patients requires standardized tasks across modalities and difficulty levels.

Purpose of the Study:

  • To evaluate emotion processing abilities in nondemented individuals with ALS.
  • To investigate deficits in facial affect recognition, voice prosody recognition, and cross-modal integration.
  • To determine the influence of cognitive status, mood, and functional impairment on emotion processing in ALS.

Main Methods:

  • Employed the abbreviated Comprehensive Affect Testing System (CATS) with 33 ALS participants and 22 controls.
  • Assessed simple and complex facial affect recognition, affective prosody recognition, and cross-modal integration.
  • Administered tests for executive function, mood, and functional impairment.

Main Results:

  • ALS participants demonstrated impairments in complex facial affect recognition, affective prosody recognition, and cross-modal integration.
  • Simple facial affect recognition and semantic comprehension of affect remained intact.
  • Emotion processing deficits were not correlated with mood or functional impairment, but cross-modal integration was linked to executive function.

Conclusions:

  • Nondemented ALS patients frequently exhibit subtle emotion recognition difficulties in both visual and auditory domains.
  • These subtle deficits can affect interpersonal interactions and overall quality of life.
  • Clinicians should consider potential emotion processing challenges in ALS patient care.